Literature DB >> 25140911

TNF receptors: signaling pathways and contribution to renal dysfunction.

Rafia S Al-Lamki1, Tanya N Mayadas2.   

Abstract

Tumor necrosis factor (TNF), initially reported to induce tumor cell apoptosis and cachexia, is now considered a central mediator of a broad range of biological activities from cell proliferation, cell death and differentiation to induction of inflammation and immune modulation. TNF exerts its biological responses via interaction with two cell surface receptors: TNFR1 and TNFR2. (TNFRs). These receptors trigger shared and distinct signaling pathways upon TNF binding, which in turn result in cellular outputs that may promote tissue injury on one hand but may also induce protective, beneficial responses. Yet the role of TNF and its receptors specifically in renal disease is still not well understood. This review describes the expression of the TNFRs, the signaling pathways induced by them and the biological responses of TNF and its receptors in various animal models of renal diseases, and discusses the current outcomes from use of TNF biologics and TNF biomarkers in renal disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25140911     DOI: 10.1038/ki.2014.285

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

1.  Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.

Authors:  Beatriz Suarez-Alvarez; José Luis Morgado-Pascual; Sandra Rayego-Mateos; Ramon M Rodriguez; Raul Rodrigues-Diez; Pablo Cannata-Ortiz; Ana B Sanz; Jesus Egido; Pierre-Louis Tharaux; Alberto Ortiz; Carlos Lopez-Larrea; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

Review 2.  Update on glycemic control for the treatment of diabetic kidney disease.

Authors:  Girish N Nadkarni; Rabi Yacoub; Steven G Coca
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

Review 3.  Emerging biomarkers of chronic kidney disease in children.

Authors:  Jason H Greenberg; Aadil Kakajiwala; Chirag R Parikh; Susan Furth
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

4.  Inflammatory proteins in diabetic kidney disease-potential as biomarkers and therapeutic targets.

Authors:  Angie S Xiang; Elif I Ekinci; Richard J MacIsaac
Journal:  Ann Transl Med       Date:  2019-09

5.  Circulating TNF receptors and risk of renal disease progression, cardiovascular disease events and mortality in patients with diabetes: a systematic review and meta-analysis.

Authors:  Dongsheng Cheng; Yang Fei; Pierre-Jean Saulnier; Niansong Wang
Journal:  Endocrine       Date:  2019-12-07       Impact factor: 3.633

6.  Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.

Authors:  Steven G Coca; Girish N Nadkarni; Yuan Huang; Dennis G Moledina; Veena Rao; Jane Zhang; Bart Ferket; Susan T Crowley; Linda F Fried; Chirag R Parikh
Journal:  J Am Soc Nephrol       Date:  2017-05-05       Impact factor: 10.121

7.  TNF Signaling Impacts Glucagon-Like Peptide-1 Expression and Secretion.

Authors:  Sufang Chen; Wei Wei; Minjie Chen; Xiaobo Qin; Lianglin Qiu; Li Zhang; Yuhao Zhang; Qi Cao; Zhekang Ying
Journal:  J Mol Endocrinol       Date:  2018-10-15       Impact factor: 5.098

Review 8.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

9.  Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.

Authors:  Natalia Nowak; Jan Skupien; Adam M Smiles; Masayuki Yamanouchi; Monika A Niewczas; Andrzej T Galecki; Kevin L Duffin; Matthew D Breyer; Nick Pullen; Joseph V Bonventre; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2018-02-02       Impact factor: 10.612

Review 10.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.